Thirumalai Chemicals Secures Rs. 65 Crore Loan from Related Party Ultramarine & Pigments Limited
Thirumalai Chemicals Limited has secured a Rs. 65 crore unsecured loan from related party Ultramarine & Pigments Limited on April 30, 2026. The 3-year loan carries 10% annual interest with quarterly compounding, payable at tenure end. The transaction involves cross-shareholding entities with UPL holding 18.23% in Thirumalai Chemicals while the company holds 14.38% in UPL, executed on arm's length basis per SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Thirumalai Chemicals Limited has announced the execution of a significant loan agreement with related party Ultramarine & Pigments Limited (UPL) for Rs. 65 crores. The agreement was formalized on April 30, 2026, under the regulatory framework of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Loan Agreement Details
The inter-corporate loan arrangement represents a strategic financial move between the two related entities. The agreement encompasses several key parameters that define the borrowing structure and repayment terms.
| Parameter: | Details |
|---|---|
| Loan Amount: | Rs. 65 Crores |
| Lender: | Ultramarine & Pigments Limited |
| Borrower: | Thirumalai Chemicals Limited |
| Interest Rate: | 10% per annum |
| Compounding: | Quarterly |
| Tenure: | 3 years |
| Nature: | Unsecured loan |
| Security: | Nil |
Related Party Relationship
The loan agreement involves parties with established business relationships and cross-shareholding arrangements. UPL is identified as a member of the promoter group of Thirumalai Chemicals Limited, creating a related party transaction scenario.
| Shareholding Structure: | Percentage |
|---|---|
| Thirumalai Chemicals' stake in UPL: | 14.38% |
| UPL's stake in Thirumalai Chemicals: | 18.23% |
Regulatory Compliance
The transaction has been structured in compliance with SEBI regulations governing related party transactions. The company has confirmed that the loan agreement has been executed on an arm's length basis, ensuring fair market terms despite the related party nature of the transaction.
Key regulatory aspects include:
- Disclosure under Regulation 30 of SEBI Listing Regulations
- Compliance with Schedule III requirements
- Adherence to SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Financial Impact
The unsecured loan facility provides Thirumalai Chemicals with access to Rs. 65 crores in funding without requiring collateral or security arrangements. The interest payment structure, with quarterly compounding at 10% per annum payable at the end of the tenure, offers flexibility in cash flow management during the 3-year loan period.
As of the date of disclosure, the amount of loan outstanding stands at nil, indicating the agreement represents a new borrowing facility rather than refinancing of existing debt. The company has filed the necessary disclosures with both NSE and BSE to maintain transparency with stakeholders and regulatory compliance.
Historical Stock Returns for Thirumalai Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.57% | +2.00% | +15.09% | -27.55% | -19.79% | +110.44% |
What specific expansion projects or capital expenditure plans will Thirumalai Chemicals fund with this Rs. 65 crore facility?
How might this increased financial leverage affect Thirumalai Chemicals' credit rating and future borrowing costs from external lenders?
Will the cross-shareholding structure between these companies lead to further strategic consolidation or merger discussions?


































